Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Yellow fever virus nonstructural protein
- Molecular classification
- Enzyme, Other (viral nonstructural protein complex)
01
Overview
Yellow fever virus nonstructural proteins are a group of viral proteins encoded by the yellow fever virus (genus Flavivirus) that are essential for viral genome replication, protein processing, assembly of infectious particles, and modulation of host immune responses[3][2][1][4]. The seven recognized nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) are produced through co- and posttranslational cleavage of the viral polyprotein. NS3 acts as a serine protease, RNA helicase, and nucleoside triphosphatase; NS5 has RNA-dependent RNA polymerase and methyl/guanylyltransferase activity. These proteins interact with each other and with structural proteins as well as host cell factors to drive the viral life cycle, making them attractive therapeutic targets for antiviral drug development[2][3][4][1].
- Other names
- YFV NS proteinsYellow fever virus NS proteinsyellow fever nonstructural proteins
02
Mechanism of action
Inhibition of RNA-dependent RNA polymerase (NS5) Inhibition of protease/helicase (NS3) Inhibition of methyltransferase function (NS5)[2][3]
03
Biological functions
Viral replicationGenome replicationViral polyprotein processingVirus assemblyImmune evasion
04
Disease associations
InfectionOther (essential for yellow fever virus pathogenesis)
05
Safety considerations
High risk of viral resistance due to RNA virus mutation ratePotential for off-target effects and toxicity related to inhibition of host homologs if drugs are not specificChallenges in broad-spectrum inhibition across flaviviruses due to sequence and functional differences
06
Interacting drugs
No approved direct-acting antivirals; however, nonstructural proteins, particularly NS3 and NS5, are recognized as promising antiviral drug targets[3][2]. Experimental compounds include RNA polymerase inhibitors and protease inhibitors.
07
Biomarkers
Not routinely used as clinical biomarkers; however, immune responses against NS1, NS3, and NS5 are measurable and have been used as markers in research and vaccine studies[6].
Beyond the preview
Go deeper on Yellow fever virus nonstructural protein.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yellow fever virus nonstructural protein.